UnitedHealth Group (NYSE:UNH) Price Target Cut to $650.00 by Analysts at UBS Group

UnitedHealth Group (NYSE:UNH) had its target price reduced by UBS Group from $680.00 to $650.00 in a research report released on Wednesday morning, Benzinga reports. They currently have a buy rating on the healthcare conglomerate’s stock.

A number of other research analysts also recently issued reports on UNH. Robert W. Baird boosted their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Stephens cut their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research report on Wednesday. HSBC lifted their price objective on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. Argus lifted their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Finally, Truist Financial reaffirmed a “buy” rating and set a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $615.58.

UnitedHealth Group Stock Up 0.6 %

UNH opened at $569.61 on Wednesday. The company has a market cap of $524.26 billion, a P/E ratio of 34.82, a P/E/G ratio of 1.69 and a beta of 0.58. The business’s 50-day moving average price is $584.42 and its 200-day moving average price is $534.15. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $608.63.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the previous year, the business earned $6.56 EPS. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group will post 27.68 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds have recently added to or reduced their stakes in the stock. Harbor Investment Advisory LLC raised its stake in UnitedHealth Group by 3.2% during the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after buying an additional 1,129 shares during the last quarter. Austin Private Wealth LLC raised its stake in UnitedHealth Group by 9.8% during the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after buying an additional 111 shares during the last quarter. Capital Insight Partners LLC raised its stake in UnitedHealth Group by 3.8% during the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after buying an additional 332 shares during the last quarter. Collective Family Office LLC increased its stake in shares of UnitedHealth Group by 4.3% in the 1st quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock worth $780,000 after purchasing an additional 65 shares in the last quarter. Finally, Global Assets Advisory LLC purchased a new stake in shares of UnitedHealth Group in the 1st quarter worth $282,469,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.